{"id":"W4387590052","doi":"10.1016/j.ijrobp.2023.08.030","title":"Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in Men with High-Risk Biochemically Recurrent Prostate Cancer and Prior Radiotherapy: EMBARK Subgroup Analysis","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Enzalutamide; Placebo; Clinical endpoint; Prostate cancer; Subgroup analysis; Hazard ratio; Internal medicine; Oncology; Radiation therapy; Urology; Confidence interval; Gynecology; Randomized controlled trial; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001701188,0.001952196,0.006194178,0.0007430158,0.000331465,0.001394015,0.000961922,0.001257169,0.004201065],"category_scores_gemma":[0.002306348,0.0007014865,0.01289949,0.0008823575,0.0004949593,0.001163193,0.0008641647,0.00231752,0.0004349246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001154986,"about_ca_system_score_gemma":0.0009996693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003993101,"about_ca_topic_score_gemma":0.01180474,"domain_scores_codex":[0.9986929,0.000497671,0.0001777873,0.0002536704,0.0001194209,0.0002585597],"domain_scores_gemma":[0.9992894,0.0002973822,0.0001449734,0.00010511,0.00005384297,0.0001092363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8554387,0.0007701517,0.01310722,0.003062062,0.09827077,0.0002356254,0.0001521698,0.001665154,0.003000978,0.0001550501,0.001758974,0.02238326],"study_design_scores_gemma":[0.4779106,0.05643805,0.1323465,0.0008189047,0.3134107,0.0004830087,0.0009694963,0.005030038,0.00198486,0.002401086,0.00786276,0.0003441289],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9445031,0.04590541,0.0012043,0.0007345382,0.0008148789,0.000871016,0.003182736,0.0001101386,0.002673971],"genre_scores_gemma":[0.9883,0.00513705,0.0005106583,0.0006714893,0.0003112359,0.0005631904,0.001741929,0.00003048179,0.002733968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006194178,"threshold_uncertainty_score":0.01405394,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01882587345047288,"score_gpt":0.348495906607532,"score_spread":0.3296700331570592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}